Your browser doesn't support javascript.
loading
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca, Marc P; Bhatt, Deepak L; Storey, Robert F; Steg, Ph Gabriel; Cohen, Marc; Kuder, Julia; Goodrich, Erica; Nicolau, José C; Parkhomenko, Alexander; López-Sendón, José; Dellborg, Mikael; Dalby, Anthony; Spinar, Jindrich; Aylward, Philip; Corbalán, Ramón; Abola, Maria Teresa B; Jensen, Eva C; Held, Peter; Braunwald, Eugene; Sabatine, Marc S.
Afiliação
  • Bonaca MP; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts. Electronic address: mbonaca@partners.org.
  • Bhatt DL; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts.
  • Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Steg PG; French Alliance for Cardiovascular Trials, Université Paris-Diderot, Paris, France.
  • Cohen M; Cardiovascular Division, Newark Beth Israel Medical Center, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Kuder J; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts.
  • Goodrich E; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts.
  • Nicolau JC; Heart Institute (InCor)-University of São Paulo Medical School, São Paulo, Brazil.
  • Parkhomenko A; Ukranian Strazhesko Institute of Cardiology, Kiev, Ukraine.
  • López-Sendón J; Hospital Universitario La Paz, Instituto de Investigación La Paz, Madrid, Spain.
  • Dellborg M; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Dalby A; Life Fourways Hospital, Randburg, South Africa.
  • Spinar J; University Hospital, Jihlavska, Brno, Czech Republic.
  • Aylward P; Division of Medicine, Cardiac & Critical Care Services, Flinders Medical Centre, South Australia, Australia.
  • Corbalán R; Cardiovascular Division, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Abola MTB; Philippine Heart Center, University of the Philippines College of Medicine, Manila, Philippines.
  • Jensen EC; AstraZeneca R&D, Mölndal, Sweden.
  • Held P; AstraZeneca R&D, Mölndal, Sweden.
  • Braunwald E; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts.
  • Sabatine MS; TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, Massachusetts.
J Am Coll Cardiol ; 67(23): 2719-2728, 2016 Jun 14.
Article em En | MEDLINE | ID: mdl-27046162
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina / Doença Arterial Periférica / Antagonistas do Receptor Purinérgico P2Y / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina / Doença Arterial Periférica / Antagonistas do Receptor Purinérgico P2Y / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article